Red Door Communications has been hired by Aventis Pasteur MSD to
restore confidence in the controversial MMR vaccine among health
Aventis has appointed Red Door to handle its travel and child vaccine
portfolios, which includes the under-fire vaccine, used to counter
mumps, measles and rubella.
MMR vaccine has been linked with bowel disorders and autism by experts
at London's Royal Free Hospital.
Red Door replaces incumbent of two years, Grayling Group, following a
two-way pitch. Grayling, which did not re-pitch, will continue to handle
Aventis's corporate account and Hepatitis B portfolio.
A six-strong team, headed by Red Door MD Catherine Warne, will handle
the account, reporting to the vaccine's project managers and Aventis
marketing director Jane Alexander.
Warne said: 'There's a big job to do with the healthcare professionals
In January the Department of Health announced it would co-ordinate a
pounds 3m campaign aimed at restoring confidence in the vaccine among
Aventis communications manager Amanda Bryett said: 'The Department of
Health is directing the campaign from the consumer side. Red Door will
target practice nurses and GPs - those who are in contact with the
Aventis's child vaccine portfolio also includes the DTP/Hib vaccine for
diphtheria, tetanus, polio and haemophilus.
Work to be carried out for the travel vaccine portfolio is aimed at
healthcare workers, but also includes a consumer educational programme
to promote the importance of getting vaccinated before travelling to
The agency will also work on the company's pneumovax II vaccine for